News and Trends 11 Dec 2018 UK Biotech Settles Lawsuit on the First RNAi Drug Silence Therapeutics and Alnylam have reached a settlement that puts an end to a legal dispute between them resulting in Silence receiving some royalties on Onpattro, the first RNA interference drug. The lawsuit started last year, when Silence went to the UK courts claiming that Alnylam was infringing on its intellectual property. As part of […] December 11, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 11 Dec 2018 Easy as ATCG: Commercialization of DNA as Data Storage You could be storing information in DNA sooner than you might think. Although the technology is still quite early — the first video encoded in DNA, revealed last year, was quite simple — the rate at which the cost of writing DNA is going down might make DNA data storage a reality in the coming […] December 11, 2018 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 10 Dec 2018 Scientists Repurpose Skin Cells to Fight Cancer Researchers have reprogrammed skin cells to make them behave like immune cell sentinels called dendritic cells, which can recruit the immune system to fight tumors. This discovery makes a step toward better cancer immunotherapy. “We are merging two different areas of research,” Carlos-Filipe Pereira, from Lund University, Sweden, said to me. “One of them is […] December 10, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2018 British Company Raises €37M to Personalize Therapies with Machine Learning Genomics, a company based in Oxford, has increased the amount raised in a Series B round that will fund further development of its genomics technology for personalized medicine. The company adds a further €9M (£8M) to the round with the participation of Foresite Capital and F-Prime Capital, two renowned US life sciences investors. The previous […] December 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 Dec 2018 Orchard’s Gene Therapy for Rare Immune Disease Works for Over a Year A single dose of a gene therapy developed by Orchard Therapeutics can restore immune function for at least a year in patients with X-linked chronic granulomatous disease (X-CGD). The gene therapy was trialed in patients between the ages of 2 and 27 with the rare disease, which is caused by a rare genetic mutation that […] December 7, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Startup Scout 7 Dec 2018 This Hypoallergenic Vaccine Could Alleviate Hay Fever Faster Than Approved Vaccines We decided to make a visit to Espoo, Finland, this week, to visit Desentum. The company is developing allergy vaccines that could be safer and faster than approved vaccines. Mission: To make a vaccine that decreases the time taken to reduce allergies compared with approved vaccines, which contain the natural allergen. Desentum plans to do […] December 7, 2018 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 6 Dec 2018 UK Project Hits 100,000 Genomes Target In a step forward for the world of personalized medicine, the UK Government-backed 100,000 Genomes Project has reached its sequencing target. The project, which is one of the largest of its kind, was designed to collect genomic data to improve the capacity of personalized medicine, as well as learning more about the genetic basis of […] December 6, 2018 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 6 Dec 2018 Update: Liver Gene Therapy 8 Times Stronger Than Usual Update (06/12/2018): uniQure has incorporated Synpromics’ strong liver promoter into a preclinical gene therapy candidate for treating hemophilia A. Published on 08/10/2018 Synpromics and uniQure have unveiled new technology for precise genetic control that could make gene therapy safer and more precise. The team has developed a gene therapy system that is highly selective for […] December 6, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Inside Labiotech 6 Dec 2018 We Are Now More Than 150,000 Awesome Biotechers Every Month Woohooo! We’ve hit 150,000 unique visitors per month to our site! What a beautiful number. We are so happy to be able to bring you great content every day and have our biotech network grow with more amazing people. Why this makes us so happy? Because it means that, 150,000 different people stopped by our website […] December 6, 2018 - 2 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
News and Trends 5 Dec 2018 Llama-Inspired Antibodies Succeed in Clinical Trials and Financial Deal Autoimmune disease and acute myeloid leukemia may have a llama-inspired antibody treatment one day. The Dutch company argenx’s antibodies have shown positive results in clinical trials, and have attracted Janssen into a collaboration to advance their use in cancer immunotherapy. In a phase II trial, the company’s lead antibody, efgartigimod, reduced the number of bleeding […] December 5, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 5 Dec 2018 How Automation Will Enable the Age of Cell Therapy Scientists in biotech and pharma spend more and more of their valuable time culturing cells manually. Automated cell culture is still not standard in the early research stages, and many believe that needs to change. Philip talked to Ali Afshar, co-founder of Cytera Cellworks to discuss how the main obstacles to bringing automation to cell […] December 5, 2018 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 4 Dec 2018 Gene Therapies for Blood Disorders Marching Through the Clinic Gene therapy holds great potential as a cure for blood disorders such as hemophilia and sickle cell disease, which have limited treatment options. This week, several gene therapy companies have released promising clinical trial results in hemophilia and sickle cell anemia. Presenting at the 2018 annual meeting of the American Society of Hematology, Dutch company uniQure […] December 4, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email